Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
How should hospitals manage the backlog of patients awaiting surgery following the COVID-19 pandemic? A demand modelling simulation case study for carotid endarterectomy Mr Guy Martin1*, Dr Jonathan Clarke2*, Mr Sheraz Markar1, Dr Alexander W. Carter3, Mr Sam
Mason1, Mr Sanjay Purkayastha1, Prof Ara Darzi1, Mr James Kinross1, on behalf of the
PanSurg Collaborative1
1 Department of Surgery and Cancer, Imperial College London, UK 2 Centre for Mathematics of Precision Healthcare, Imperial College London, UK 3 Department of Health Policy, London School of Economics & Political Science
* Joint first authors
PanSurg Collaborative:
Ravi Aggarwal, Rabiya Aseem, Piers Boshier, Paris Bratsos, Swathikan Chidambaram,
Emily Deurloo, Simon Dryden, Simon Erridge, Maxwell Flitton, Ayush Kulshreshtha, Max
Denning, Emily Deurloo, Ola Markiewicz, Osama Moussa, Liam Poynter, Simon Rabinowicz,
Ovidiu Serban, Alasdair Scott, Viknesh Sounderajah, Uddhav Vaghela, Leigh Warren,
Jasmine Winter-Beatty, Seema Yalamanchili
Corresponding Author:
Guy Martin
Department of Surgery and Cancer
Imperial College London
10th Floor QEQM Building, St Mary’s Hospital
London, W2 1NY
Conflicts of interest:
All authors declare no support from any organisation for the submitted work; no financial
relationships with any organisations that might have an interest in the submitted work in the
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
previous three years; no other relationships or activities that could appear to have influenced
the submitted work.
Data Sharing:
All original code and data will be available from the corresponding author upon reasonable
request.
Funding:
The research was supported by the National Institute for Health Research (NIHR)
Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial
College London.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Abstract
Background
The COVID-19 pandemic presents unparalleled challenges for the delivery of safe and
effective care. In response, many health systems have chosen to restrict access to surgery
and reallocate resources; the impact on the provision of surgical services has been
profound, with huge numbers of patient now awaiting surgery at the risk of avoidable harm.
The challenge now is how do hospitals transition from the current pandemic mode of
operation back to business as usual, and ensure that all patients receive equitable, timely
and high-quality surgical care during all phases of the public health crisis.
Aims and Methods
This case study takes carotid endarterectomy as a time-sensitive surgical procedure and
simulates 400 compartmental demand modelling scenarios for managing surgical capacity in
the UK for two years following the pandemic.
Results
A total of 7,69 patients will require carotid endarterectomy. In the worst-case scenario, if no
additional capacity is provided on resumption of normal service, the waiting list may never
be cleared, and no patient will receive surgery within the 2-week target; potentially leading to
>1000 avoidable strokes. If surgical capacity is doubled after 1-month of resuming normal
service, it will still take more than 6-months to clear the backlog, and 30.8% of patients will
not undergo surgery within 2-weeks, with an average wait of 20.3 days for the proceeding 2
years.
Conclusions
This case study for carotid endarterectomy has shown that every healthcare system is going
to have to make difficult decisions for balancing human and capital resources against the
needs of patients. It has demonstrated that the timing and size of this effort will critically
influence the ability of these systems to return to their baseline and continue to provide the
highest quality care for all. The failure to sustainably increase surgical capacity early in the
post-COVID-19 period will have significant long-term negative impacts on patients and is
likely to result in avoidable harm.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Introduction
The current COVID-19 pandemic is the biggest threat to health in living memory and
presents unparalleled challenges for the delivery of safe and effective care at scale across
all health systems, which have not been considered before. The pandemic has placed
unprecedented pressures on acute healthcare resources and capacity; demand has
overwhelmed even the most developed and well-resourced health systems[1], and difficult
decisions regarding the rationing of care have now been made[2]. In response to the
pandemic, many health systems have chosen to restrict access to surgical procedures and
reallocate resources in order to create additional short-term hospital capacity[3–7]; the
impact on the provision of surgical services has been profound with more than two million
procedures cancelled to date in the UK at a cost of £3bn[8]. Patients will continue to develop
a full range of pathologies as the pandemic progresses, continually contributing to the
demand for post-pandemic surgical services. Ultimately, this will further exacerbate waiting
times, cause preventable morbidity and mortality from surgical disease and adversely affect
quality of life. As healthcare systems attempt to regain the initiative, policy makers and
administrators must now determine how these systems adapt to meet their elective
responsibilities and transition from the current crisis mode of operation back to ‘business as
usual’. The challenge is to manage patient demand for surgery during all phases of the
pandemic whilst ensuring equitable, timely and high-quality care for all. However, no models
currently exist that allow policy makers to develop strategies for achieving this goal.
Stroke is one of the leading causes of death and long-term disability[9], and places a large
burden on health systems, patients and their relatives. The principal cause of stroke is
carotid territory ischaemia, with up to 15% of all cases attributable to significant carotid
artery stenoses[10]. Carotid endarterectomy (CEA) is one of the most studied surgical
procedures, and there is little controversy regarding its benefit in those with moderate to
high-grade stenosis, with up to a 53% relative reduction in stroke risk compared to best
medical therapy alone, and with optimal outcomes seen when surgery is performed within
two weeks of symptoms[11,12]. Whilst there is some evidence for a decline in the number of
procedures performed annually across the world[13,14], carotid endarterectomy remains a
relatively common procedure with approximately 4,000 cases performed annually in the
United Kingdom[15]. National bodies such as The Vascular Society for Great Britain and
Ireland have issued guidance suggesting that surgeons should still try to operate on high risk
patients during the pandemic, but that aggressive best medical therapy may be more
appropriate[16]; the impact of COVID-19 on carotid surgery has been hugely significant.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
This study therefore takes CEA as a case study for an evidence-based time-sensitive
surgical procedure, and then seeks to simulate a range of demand modelling scenarios for
managing surgical capacity after the pandemic has concluded in order to return to business
as usual within the United Kingdom’s National Health Service (NHS). These models provide
valuable insights that are applicable to all surgical procedures and health systems.
Methods Compartmental Demand Model:
A compartmental model was constructed to represent a range of scenarios for increasing
surgical capacity for CEA following total cessation of surgical services in response to the
COVID-19 pandemic. There is no monthly variation in stroke rates[17], and so for the
purposes of the model a constant weekly rate of demand for CEA was assumed based on
the number of procedures performed for symptomatic carotid disease in the United Kingdom
in 2018; equating to 74 cases per week[15]. In addition, it was assumed that at baseline
demand matches system capacity.
Figure 1 shows the components of the model used. Each week, a finite number of patients
from an infinite pool of potential patients are assumed to require carotid endarterectomy.
These patients are added to the list of patients awaiting surgery. Each week, a finite number
of patients are taken from this list and undergo surgery. Patients are selected on a ‘first
come, first served’ basis, and so the patients operated on each week are those that have
waited longest for surgery. In each model it is assumed that no carotid endarterectomies are
performed for three months (13 weeks) due to COVID-19, after which surgery resumes.
Throughout this period, new patients continue to require carotid endarterectomies at a
constant rate of 74 cases per week. In the model it was assumed that once deemed to
require surgery, all patients remained eligible and survived to undergo their procedure
irrespective of delay.
Different scenarios for the capacity to perform carotid endarterectomies were simulated
subject to two distinct parameters; the time taken to return to baseline capacity (TTB) and
the eventual additional capacity reached above pre-COVID-19 capacity (EC). Capacity is
assumed to increase at a constant rate until EC is reached. Models were simulated for the
two years after the initial cessation of surgical services for twenty different TTB values,
ranging from 0 to 19 weeks, and 20 different EC values, ranging from 0% to 100% of
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
baseline capacity. Figure 2 illustrates three of the 400 potential capacity scenarios
examined. Model 1 indicates an immediate return to pre-COVID-19 baseline capacity of 74
cases per week (TTB = 0, EC = 100), which thereafter remains constant. Model 2 indicates a
return to pre-COVID-19 baseline capacity at 4 weeks, after which capacity continues to
increase at the same rate to reach 20% above baseline capacity (TTB = 4, EC = 20). Model
3 indicates a slower return to baseline capacity, taking 8 weeks, after which capacity
continues to increase to 40% above baseline capacity (TTB = 8, EC = 40). In each case
once eventual capacity is reached, the number of procedures performed remains constant at
this rate.
The full mathematical model and code is available on request from the authors. All
simulation, analysis and production of figures was conducted using Python V3.6.8 (Python
Software Foundation, www.python.org) using the pandas, numpy, matplotlib and scikit.learn
libraries.
Outcome Measures:
The primary outcome measure reported is the mean waiting time for patients newly requiring
carotid endarterectomy in the two years from the start of the period of cessation of surgery.
The time taken for the waiting list to be eliminated, and the proportion of patients waiting 2
weeks and 12 weeks for surgery are reported as secondary outcome measures. These were
selected based on data derived from the most recent pooled analysis of 6,092 patients with
35,000 years of follow-up that shows maximal benefit from surgery when performed within 2
weeks of symptoms, and no benefit after a wait of more than 12 weeks[11]. Contour plots
were produced using cubic interpolation of scatter points to represents scenarios of equal
values with respect to the above outcome measures.
Results A total of 7,696 patients were assumed to require carotid endarterectomy in the two years
following the start of cessation of surgical services. Where surgical capacity immediately
returns to pre-COVID-19 capacity of 74 cases per week (Mode 1, Figure 2), surgical
capacity equals surgical demand, and therefore waiting lists remain at a constant size of 962
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
cases after the resumption of surgery. The waiting list does not reduce, owing to new
demand being equal to the number of cases performed each week.
Figure 3 shows the performance of the 400 models simulated with respect to the average
time waited for surgery, the time taken for the waiting list to be eliminated and the proportion
of patients waiting more than 2 and 12 weeks for surgery is shown.
Figure 3A shows that above an EC of 40%, the average time waited for surgery is primarily
dictated by the TTB, while for EC of less than 20%, EC is more influential with respect to
average waiting time than TTB. For a 20% increase in capacity above baseline, an average
waiting time of 12 weeks can only be achieved if pre-COVID-19 baseline capacity is reached
in fewer than 10 weeks. Where eventual additional capacity is double pre-COVID-19
baseline capacity, if TTB is 8 weeks, patients would on average wait 4 weeks for surgery.
Figure 3B shows the time taken for the additional waiting list to be eroded is more than two
years where capacity is increased above pre-COVID-19 baseline capacity by less than 20%,
unless capacity is returns to baseline in less than 3 weeks. For capacity increases of 10% or
less, the additional waiting list is not eroded completely for at least three years. Even if
capacity is doubled, unless baseline capacity is reached within three months, it would take at
least a year to erode the additional waiting list as a result of cessation of surgical services.
Under all scenarios, the additional waiting list persists for at least 6 months.
Figure 3C shows a 30% increase in capacity above the pre-COVID-19 baseline, coupled
with a TTB of 0 weeks is required for more than 50% of patients to receive a carotid
endarterectomy within 2 weeks in the two years following cessation of services. In scenarios
where pre-COVID-19 baseline capacity is reached after two months following resumption of
surgical services, capacity increases of 60% or more are required to ensure half of patients
receive surgery in less than 2 weeks.
Figure 3D shows where capacity is increased to 20% or more above baseline capacity, 50%
or more of patients receive carotid endarterectomies within 12 weeks. For capacity
increases of less than 20%, the time taken to return to baseline capacity strongly influences
the proportion of patients operated on within 12 weeks.
Discussion
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
The cessation of the majority of surgery has had a profound impact on services and will
undoubtedly lead to huge increases in patients awaiting intervention as the incidence of non-
traumatic surgical pathology is unlikely to change as a result of the pandemic. Whilst the
initial priority for policy makers and clinicians was rightly managing the acute phase of the
pandemic, the next, and potentially far bigger challenge is determining how and when
hospitals return to business as usual in what will be a post-pandemic new normal.
This demand modelling scenario has shown that following a 3-month cessation of carotid
endarterectomy surgery, if no additional capacity is provided on resumption of normal
service the waiting list will not be cleared for over 2 years, and the vast majority of patients
would wait >12 weeks for surgery at which point it is of no benefit; exposing them to double
the risk of stroke and resulting in the region of 350-1100 additional strokes[11]. Even if
surgical capacity is doubled after 1-month of resuming normal service it will still take over 6-
months to clear the waiting list backlog, 30.8% of patients will not undergo surgery within the
2-week target, and 11.5% will wait more than 12-weeks with an average wait to surgery of
20.3 days for the proceeding 2 years; resulting in the region of 100-350 additional strokes. It
should also be noted that this modelling technique is not specific to CEA, with delays in
surgery from a post-COVID-19 backlog in cases likely to have a direct impact on patients
across a wide range of diagnoses. Given these sobering figures hospitals must now start to
look forwards and plan for how they can and should manage capacity to ensure they provide
equitable, timely and high-quality care for all in the post-COVID-19 recovery phase.
Increasing capacity to deal with excess demand is not straight forward, with multiple factors
influencing the ability of hospitals to increase the number of surgical procedures performed
and clear the post-COVID-19 backlog.
External factors may include unpredictable changes in the rate of new stroke diagnoses due
to a reduction in the number of patients presenting with acute symptoms during the
pandemic; changes which have already been reported across a range of diagnoses
including in stroke[18,19]. This phenomenon will be of even greater importance in diseases
with more complex referral and treatment patterns such as gastrointestinal cancer where the
majority of patients move between primary care, screening services, diagnostics and
hospitals prior to receiving surgery. Additionally, there are going to be inevitable further
spikes in COVID-19 cases until either a vaccine is developed or herd immunity is
achieved[20]. This will lead to further fluctuations in surgical capacity and successive shut
downs over time; it is therefore it is important to meaningfully catch up when excess capacity
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
is possible, and more elegantly decrease surgical capacity without a total shutdown during
future spikes to ensure we are not once again starting from a standstill.
In addition to external factors, multiple internal considerations will also influence the ability to
increase capacity and catch up with a surgical backlog as highlighted in current capacity
planning models[21]. Surgical teams do not operate in isolation, and critical care capacity is
vital to support a wide range of surgical procedures including CEA. The COVID-19 pandemic
has led to a huge increase in demand for critical care capacity that will likely continue into
the medium- and long-term[22,23], and even before the crisis critical care units typically had
occupancy rates of around 80-85%[24,25] with significant variability in the availability of
critical care capacity in relation to surgical activity[26]. Surgical teams can therefore not
depend on predictable levels of critical care availability to support an increase in capacity
and so will need to plan accordingly or modify peri-operative practice. It is not just critical
care capacity that may limit the ability to rapidly expand surgical services. The NHS in
England typically runs at general bed occupancy rates of 90-95%[27], and therefore its
ability to rapidly expand surgical numbers is severely limited without seeking alternative
infrastructure. Potential options could include the use of the private healthcare sector or
transitioning temporary facilities such as the NHS Nightingale Hospitals that were built in
response to the COVID-19 crisis to more permanent facilities geared towards reducing
waiting lists by providing additional capacity. The most important resource for clearing
surgical waiting lists is staff though. Burnout is an increasingly recognised phenomena
across all healthcare workers, and especially in those delivering surgical services[28,29].
Compounding this will be the knock on effects of the huge increases in work intensity, the re-
deployment of staff across different services and the consequences of the sobering 20%
COVID-19 infection rates in healthcare staff[30]. Even if physical capacity is found,
healthcare providers must carefully look after, protect and support their staff to ensure that
the post-COVID-19 response and return to business as usual is both successful and
sustainable; healthcare workers are human, and have limits.
The model presented does have limitations. It assumes all patients remain eligible for
intervention and survive to undergo their procedure irrespective of delay. Within the CEA
cohort there is likely to be in the region of a 10-20% annual dropout rate due to death or
further stroke that makes someone ineligible for surgery, with the greatest risk seen in the
first three months[31,32]. This would act to reduce the number of patients requiring
intervention, and thus the time to return to baseline, but the impact will be minimal;
importantly, the model represents the worst-case scenario for which health systems should
plan for, and act on. In addition, this is a generalised model based on national figures. As
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
such, there is a requirement for individual organisations to take into account local factors
such as the direct disruption caused by COVID-19, competing demands of surgical and
supporting services, and wider infrastructure and staffing resource constraints when
designing, modelling and implementing local recovery plans.
To further refine the models and identify contextual solutions, discrete event simulations
could be employed to incorporate probabilistic payoffs on decisions around additional factors
such as mortality rates, the social acceptability of delays and impact of local and national
prioritisation and planning decisions. It is also important to assess the financial and human
capital implications of seeking to increase surgical capacity. To address the avoidable
burden of stroke, the health implications and costs of these policy decisions could be
expressed as incremental gains or losses in quality adjusted life years (QALY). We
recommend that future analyses incorporate these cost indicators, in addition to risk-based
decision aids to help health systems allocate their finite resources to maximise patient
benefit.
The cessation of the majority of global elective surgical services during the Covid-19
pandemic has had a profound impact on patients and healthcare providers. This case study
for carotid endarterectomy has shown that every healthcare system is going to have to make
difficult decisions when balancing human and capital resources against the needs of
patients. It has also demonstrated that the timing and size of this effort will critically influence
the ability of these systems to return to their baseline and continue to provide the highest
quality care for all. The failure to sustainably increase surgical capacity early in the post-
COVID-19 era will have significant long-term negative impacts on patients and is likely to
result in avoidable harm.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Figure 1 - schematic of demand model components
Patients awaiting surgery
Patients undergoingsurgery
New patients requiring surgery
Potential Patients
Post-operativePatients
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Figure 2 - three illustrative examples of surgical capacity scenarios varying according
to the time to return to pre-COVID-19 baseline capacity (TTB) and the eventual capacity reached (EC) following complete cessation of surgery for three months.
Model 1) pre-COVID-19 capacity is restarted on day 1 and maintained. Model 2) pre-COVID-19 capacity is reached after 4 weeks and then increases to reach 20% above
baseline. Model 3) pre-COVID-19 capacity is reached after 8 weeks and then increases to reach 40% above baseline
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Figure 3 - contour plots showing the performance of simulation models over varying times to return to baseline capacity (TTB) on the y-axis and the eventual additional capacity reached (EC) on the x-axis for patients requiring surgery within 2 years of the onset of the 3-month cessation of surgery. A) average wait time for patients to
undergo surgery. B) time to clear waiting list and return to baseline. C) proportion of patients undergoing surgery within 2 weeks. D) proportion of patients undergoing
surgery within 12 weeks
A B
C D
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
References
1 Moghadas SM, Shoukat A, Fitzpatrick MC, et al. Projecting hospital utilization during
the COVID-19 outbreaks in the United States. Proc Natl Acad Sci U S A 2020;:1–5.
doi:10.1073/pnas.2004064117
2 Emanuel EJ, Persad G, Upshur R, et al. Fair allocation of scarce medical resources in
the time of Covid-19. N Engl J Med 2020;:1–7. doi:10.1056/nejmsb2005114
3 Lancaster EM, Sosa JA, Sammann A, et al. Rapid response of an academic surgical
department to the COVID-19 pandemic: implications for patients, surgeons, and the
community. J Am Coll Surg Published Online First: 9 April 2020.
doi:10.1016/j.jamcollsurg.2020.04.007
4 Weber Lebrun E, Moawad N, Rosenberg E, et al. COVID-19 pandemic: staged
management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol
2020;0. doi:10.1016/j.ajog.2020.03.038
5 Rajan N, Joshi G. The COVID-19: role of ambulatory surgery facilities in this global
pandemic. Anesth Analg Published Online First: 2020.
doi:10.1213/ane.0000000000004847
6 Ng J, Ho P, Dharmaraj R, et al. The global impact of COVID-19 on vascular surgical
services. J Vasc Surg Published Online First: 1 April 2020.
doi:10.1016/j.jvs.2020.03.024
7 Ross SW, Lauer CW, Miles WS, et al. Maximizing the calm before the storm: tiered
surgical response plan for novel coronavirus (COVID-19). J Am Coll Surg Published
Online First: 30 March 2020. doi:10.1016/j.jamcollsurg.2020.03.019
8 Sample I. More than 2m operations cancelled as NHS fights Covid-19. Guard.
2020.https://www.theguardian.com/society/2020/apr/26/more-than-two-million-
operations-cancelled-as-nhs-fights-covid-19
9 Truelsen T, Piechowski-Jóźwiak B, Bonita R, et al. Stroke incidence and prevalence
in Europe: a review of available data. Eur J Neurol 2006;13:581–98.
doi:10.1111/j.1468-1331.2006.01138.x
10 Kolominsky-Rabas P, Weber M, Gefeller O, et al. Epidemiology of ischaemia stroke
subtypes according to TOAST criteria. Stroke 2001;32:2735–40.
doi:10.1016/j.ncl.2016.06.013
11 Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
Cochrane Database Syst Rev 2017;:CD001081.
doi:10.1002/14651858.CD001081.pub3.www.cochranelibrary.com
12 Naylor AR, Ricco JB, de Borst GJ, et al. Editor’s choice – management of
atherosclerotic carotid and vertebral artery disease: 2017 Clinical Practice Guidelines
of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg
2018;55:3–81. doi:10.1016/j.ejvs.2017.06.021
13 Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics’2017
Update: A Report from the American Heart Association. Circulation 2017;135:e146–
603. doi:10.1161/CIR.0000000000000485
14 Johal AS, Loftus IM, Boyle JR, et al. Changing pateerns of carotid endarterectomy
between 2011 and 2017 in England: a population-based cohort study. Stroke
2019;50:2461–8. doi:10.1161/STROKEAHA.119.025231
15 Waton S, Johal A, Heikkila K, et al. National Vascular Registry 2019 Annual Report.
London, UK: 2019.
16 Vascular Society of Great Britain and Ireland. COVID-19 and Vascular Surgery.
2020.https://www.vascularsociety.org.uk/_userfiles/pages/files/Newsletters/2020/Presi
dents update 27_03_20.pdf (accessed 26 Apr 2020).
17 Li Y, Zhou Z, Chen N, et al. Seasonal variation in the occurrence of ischemic stroke: A
meta-analysis. Environ Geochem Health 2019;41:2113–30. doi:10.1007/s10653-019-
00265-y
18 Morelli N, Rota E, Terracciano C, et al. The baffling case of ischemic stroke
disappearance from the casualty department in the COVID-19 era. Eur Neurol
2020;:1–3. doi:10.1159/000507666
19 West D. Some hospitals left ‘quiet’ as covid-19 sparks huge fall in attendances. Heal
Serv J 2020.https://www.hsj.co.uk/acute-care/some-hospitals-left-quiet-as-covid-19-
sparks-huge-fall-in-attendances/7027244.article (accessed 26 Apr 2020).
20 Xu S, Li Y. Beware of the second wave of COVID-19. Lancet Published Online First:
2020. doi:10.1016/S0140-6736(20)30845-X
21 MRC Centre for Global Infectious Disease Analysis. Hospital Planning Tool. COVID-
19 Plan. Tools. 2020.https://www.imperial.ac.uk/mrc-global-infectious-disease-
analysis/covid-19/covid-19-planning-tools/ (accessed 28 Apr 2020).
22 Shoukat A, Wells C, Langley J, et al. Projecting demand for critical care beds during
COVID-19 outbreaks in Canada. Can Med Assoc J 2020;:cmaj.200457.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint
doi:10.1503/cmaj.200457
23 Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary
emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia
Published Online First: 4 April 2020. doi:10.1111/anae.15072
24 Wunsch H, Wagner J, Herlim M, et al. ICU occupancy and mechanical ventilator use
in the united states. Crit Care Med 2013;41:2712–9.
doi:10.1097/CCM.0b013e318298a139
25 The Kings Fund. Critical care services in the English NHS.
2020.https://www.kingsfund.org.uk/publications/critical-care-services-nhs (accessed
26 Apr 2020).
26 Wong DJN, Popham S, Wilson AM, et al. Postoperative critical care and high-acuity
care provision in the United Kingdom, Australia, and New Zealand. Br J Anaesth
2019;122:460–9. doi:10.1016/j.bja.2018.12.026
27 The Kings Fund. NHS hospital bed numbers.
2020.https://www.kingsfund.org.uk/publications/nhs-hospital-bed-numbers (accessed
26 Apr 2020).
28 Lilly C, Cucchi E, Marshall N, et al. Battling intensivist burnout: a rtole for workload
management. Chest. 2019;156:1001–7. doi:10.1016/j.chest.2019.04.103
29 Hu YY, Ellis R, Hewitt DB, et al. Discrimination, abuse, harassment, and burnout in
surgical residency training. In: New England Journal of Medicine. Massachussetts
Medical Society 2019. 1741–52. doi:10.1056/NEJMsa1903759
30 Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020;2:10–3.
doi:10.1016/S0140-6736(20)30627-9
31 Singh RJ, Chen S, Ganesh A, et al. Long-term neurological, vascular, and mortality
outcomes after stroke. Int J Stroke 2018;13:787–96. doi:10.1177/1747493018798526
32 Vernino S, Brown R, Sejvar J, et al. Cause-specific mortality after first cerebral
infarction: A population-based study. Stroke 2003;34:1828–32.
doi:10.1161/01.STR.0000080534.98416.A0
. CC-BY-NC-ND 4.0 International licenseIt is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 2, 2020. .https://doi.org/10.1101/2020.04.29.20085183doi: medRxiv preprint